<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Robert F. Kennedy Jr | News Central Site</title>
    <link>https://newscentral.site/profile/robert-f-kennedy-jr/</link>
    <description>26th United States Secretary of Health and Human Services since 2025</description>
    <language>en</language>
    <lastBuildDate>Tue, 17 Nov 2026 23:01:13 GMT</lastBuildDate>
    <generator>News Central Site platform</generator>
    <copyright>News Central Site. CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/): free to republish with credit to News Central Site and a link to the story. Photos not included.</copyright>
    <atom:link href="https://newscentral.site/profile/robert-f-kennedy-jr/rss.xml" rel="self" type="application/rss+xml"/>
    <atom:link href="https://pubsubhubbub.appspot.com/" rel="hub"/>
    <item>
      <title>Measles-free status lost by US after decades of effort</title>
      <link>https://newscentral.site/measles-free-status-lost-by-us-after-decades-of-effort/</link>
      <guid isPermaLink="true">https://newscentral.site/measles-free-status-lost-by-us-after-decades-of-effort/</guid>
      <pubDate>Tue, 17 Nov 2026 21:30:23 GMT</pubDate>
      <dc:creator>News Central Site</dc:creator>
      <category>World</category>
      <description><![CDATA[The United States has lost its measles-free status after decades of concerted efforts to eradicate the highly contagious virus.]]></description>
      <content:encoded><![CDATA[<p>The United States has lost its measles-free status after decades of concerted efforts to eradicate the highly contagious virus.</p><p>This reversal is part of a disturbing trend in which vaccination rates are declining globally and locally, allowing once-controlled diseases to resurface and spread rapidly.</p><p>Measles cases have been on the rise across the Americas since 2024, with multiple countries struggling to contain outbreaks. The US has now joined Mexico and Bolivia as nations where measles elimination efforts have faltered.</p><p>Mexico's loss of measles-elimination status is a direct result of a significant resurgence of the virus in the country, which culminated in a massive outbreak in Chihuahua state.</p><p>Bolivia also lost its measles-elimination status after struggling to contain outbreaks across the nation.</p><p>The Pan American Health Organization (PAHO) has announced that it expects the US, Bolivia, and Mexico to submit plans within weeks on how they will work towards stopping measles transmission for at least a year and regaining their measles elimination status.</p><p>Measles outbreaks have been spreading across the Americas since 2024, initially affecting close-knit Mennonite communities in North America before expanding to areas with low vaccination rates. Last year, Canada lost its measles-free designation for the first time since 1998, highlighting the growing concern over vaccine-preventable diseases.</p><p>The measles elimination status is based on whether a single chain of transmission has not occurred within a country's resident population for at least 12 consecutive months. This designation is crucial in assessing a region's public health preparedness and ability to control infectious disease outbreaks.</p><p>Vaccination rates have been declining globally, including in the US, raising concerns about the resurgence of vaccine-preventable diseases like measles. As one of the most contagious diseases known to medicine, measles was seen as a likely candidate to reemerge when vaccination efforts falter.</p><p>According to Dr. Susan Kansagra, chief medical officer of the Association of State and Territorial Health Officials, measles outbreaks can serve as an early warning sign for other vaccine-preventable diseases.</p><p>The spread of measles in communities across the United States has become a growing concern due to declining vaccination rates and federal leaders' mixed messages about the importance of getting vaccinated.</p><p>A significant drop in community vaccination rates below 95% has created an environment where outbreaks can occur, according to experts. The virus is now present in all but three states, with confirmed cases reported throughout the country this year.</p><p>The past two years have seen a surge in measles cases, with over 7,000 reported and 13 related deaths. The majority of those affected were either not vaccinated or their vaccination status was unknown. Furthermore, nearly 10% of infected individuals required hospitalization for treatment.</p><p>Measles typically begins with a high fever followed by a distinctive rash that starts on the face before spreading to other areas of the body. Most people recover from the illness, but it remains one of the leading causes of death among young children worldwide according to the World Health Organization.</p><p>The sudden surge in measles cases across the United States has led to a significant increase in reported illnesses and fatalities. In Texas alone, over 760 people have fallen ill and two children have lost their lives due to the highly contagious disease.</p><p>Measles outbreaks have also been reported in neighboring states such as New Mexico, Arizona, Utah, and South Carolina. The situation is dire, particularly in rural border towns where access to healthcare services may be limited. In New Mexico, approximately 100 people contracted measles, resulting in one adult fatality.</p><p>The current outbreak has surpassed all previous ones since 1991, with over 5,400 confirmed cases reported so far this year. This staggering number is already double the total for last year and is largely attributed to a massive outbreak in Pennsylvania. The sheer scale of the epidemic has left public health experts warning that the actual numbers may be significantly higher.</p><p>The US government's handling of the measles crisis has been criticized by some, particularly given the leadership roles held by individuals with a history of anti-vaccination advocacy. Robert F. Kennedy Jr., the US Health Secretary, was once a vocal proponent of vaccine skepticism before taking on his current role.</p><p>The struggles with measles in various countries are well-documented, but experts argue that the situation in the US wasn't predetermined.</p><p>Senator Ron Wyden from Oregon has expressed his disappointment and frustration over the loss of measles-free status, labeling it a "tragic yet predictable outcome.</p><p>A significant step taken by the government to combat the spread of measles is the allocation of $100 million to support state and local health departments in their response efforts.</p><p>CDC Director Dr. Erica Schwartz reaffirmed the importance of vaccination in preventing measles transmission, stating that vaccination does" protect Americans from the disease.</p><p>However, state and local health officials have pointed out that the cost of addressing this issue far exceeds the allocated funds, emphasizing the need for a stronger federal commitment to vaccinations.</p><p>The lack of vocal support for vaccination efforts from high-ranking officials has been criticized by experts, who warn that inaction will only lead to more suffering.</p><p>The lack of urgency from top officials has raised concerns among health experts as the US, Mexico, and Bolivia struggle to contain the measles outbreak. An inquiry about Kennedy's reaction to the US losing its measles-free status was met with a reference to Schwartz's statement by an HHS spokesperson.</p><p>Health officials have previously credited successful vaccination campaigns for eradicating measles in the Americas, where over 6.2 million deaths were prevented between 2000 and 2023. The region's achievement in becoming the world's first measles-free area is now at risk as North America grapples with a renewed outbreak.</p><p><em>France 24 English</em>: <a href="https://www.france24.com/en/americas/20261117-us-mexico-and-bolivia-lose-measles-free-status-as-deaths-mount">https://www.france24.com/en/americas/20261117-us-mexico-and-bolivia-lose-measles-free-status-as-deaths-mount</a></p>]]></content:encoded>
      <enclosure url="https://newscentral.site/media/us-mexico-and-bolivia-lose-measles-free-status-as-deaths-mount.webp" type="image/webp" length="0"/>
      <media:content url="https://newscentral.site/media/us-mexico-and-bolivia-lose-measles-free-status-as-deaths-mount.webp" medium="image" width="1280" height="720"><media:title>Measles-free status lost by US after decades of effort</media:title></media:content>
    </item>
    <item>
      <title>Measles Elimination Status at Risk for US and Mexico</title>
      <link>https://newscentral.site/measles-elimination-status-at-risk-for-us-and-mexico/</link>
      <guid isPermaLink="true">https://newscentral.site/measles-elimination-status-at-risk-for-us-and-mexico/</guid>
      <pubDate>Fri, 13 Nov 2026 09:00:41 GMT</pubDate>
      <dc:creator>News Central Site</dc:creator>
      <category>Health</category>
      <description><![CDATA[International health experts will assess whether the US and Mexico have lost their measles elimination status due to recent outbreaks.]]></description>
      <content:encoded><![CDATA[<p>International health experts are gathering in a closed-door meeting this week to assess whether the US and Mexico have lost their measles elimination status, a major public health achievement.</p><p>The US had been measles-free for over three decades, with the disease becoming a rarity and deaths from it virtually unheard of. However, large outbreaks have occurred in multiple states over the past two years, resulting in thousands of illnesses and about a dozen deaths.</p><p>Measles is an extremely contagious disease that has spread rapidly across North America since 2024. The meeting, convened by the Pan American Health Organization (PAHO), will determine if the same measles virus has been continuously spreading within the US and Mexico's borders for over a year.</p><p>Experts expect the meeting to show that measles has officially returned to both countries, marking a significant setback in public health efforts. The decision would be a major blow to the progress made in eliminating the disease.</p><p>The implications of losing measles elimination status are far-reaching, with Dr. David Margolius, director of Cleveland's health department, describing it as "a big deal" that represents moving backwards on public health achievements.</p><p>The commission's decision to strip the US and Mexico of their measles elimination status will be based solely on genetic factors, according to Dr. Amesh Adalja, an infectious disease expert at Johns Hopkins Center for Health Security.</p><p>If the commission finds that the countries can no longer meet the criteria for eliminating measles, PAHO officials will inform Director Jarbas Barbosa, a former Brazilian health official, who will make the final determination. An announcement of the findings is scheduled to take place next week, according to PAHO officials.</p><p>The loss of measles elimination status does not mean that federal health officials will change their approach to addressing outbreaks, according to CDC Director Erica Schwartz. She emphasized in a statement that vaccination remains the key to protecting Americans from measles and other infectious diseases.</p><p>Public health experts are calling for a more vigorous campaign to promote vaccinations and provide guidance to doctors, citing what they see as a muted federal response to the ongoing outbreak. They point out that US Health Secretary Robert F. Kennedy Jr.'s past involvement in the anti-vaccine movement has contributed to the current situation.</p><p>The proposed changes to the vaccine schedule have sparked concerns among health experts who fear they could lead to a decline in vaccination rates.</p><p>Measles can be a serious illness, causing high fever and a distinctive rash that typically starts on the face and neck. In some cases, it can result in blindness or swelling of the brain, especially in young children and adults over 30.</p><p>The US had made significant progress in reducing measles cases, achieving elimination status in 2000 after decades of vaccination efforts. However, maintaining high vaccination rates is crucial to prevent outbreaks when an infected individual enters a community.</p><p>A minimum of 95% vaccination rate is considered necessary to ensure that communities remain protected against measles outbreaks. Experts warn that slipping below this threshold could have severe consequences for public health.</p><p>The US has seen its childhood vaccination rates decline in recent years, partly due to misinformation about the safety and efficacy of vaccines.</p><p>Measles cases in the US have skyrocketed, with over 5,100 confirmed instances this year already surpassing the total for 2025. The majority of these cases can be attributed to a massive outbreak in Pennsylvania that has overshadowed earlier outbreaks in other states.</p><p>The alarming surge in measles cases is not limited to the number of infections but also comes with devastating consequences. So far this year, eight measles-related deaths have been recorded, marking one of the highest tolls in over three decades. This grim milestone marks a stark contrast to the 1991 record, when the country was plagued by a similar outbreak.</p><p>Mexico's own struggle with measles is equally concerning, with vaccination efforts hindered by a delayed introduction of the measles vaccine. It wasn't until years after its US counterpart was first licensed in 1963 that Mexico began administering shots. The nation didn't achieve measles elimination status until 2016.</p><p>The spread of measles in Mexico can be linked to an outbreak in the northern border state of Chihuahua, which researchers believe stemmed from an unvaccinated child who traveled to Texas and returned infected. This incident highlights the interconnectedness of public health issues across borders.</p><p>Reports from around the world indicate that several countries have lost their measles elimination status, including Armenia, Austria, Azerbaijan, Spain, the UK, and Uzbekistan. The World Health Organization confirmed these losses at the beginning of this year, underscoring the global nature of the measles crisis.</p><p>The US and Mexico are on the cusp of surrendering a significant health triumph, as efforts to eradicate measles in both countries continue to face major setbacks.</p><p>A combination of factors has contributed to this precarious situation, including declining vaccination rates and the spread of misinformation about vaccine safety. The World Health Organization's confirmation of these losses at the beginning of this year underscored the global nature of the measles crisis. With many lives still at risk, it remains to be seen whether a reversal can be achieved before further damage is done.</p><p><em>ABC News Health</em>: <a href="https://abcnews.com/Health/wireStory/us-mexico-verge-forfeiting-major-health-victory-138102185">https://abcnews.com/Health/wireStory/us-mexico-verge-forfeiting-major-health-victory-138102185</a></p>]]></content:encoded>
      <enclosure url="https://newscentral.site/media/us-mexico-are-on-the-verge-of-forfeiting-a-major-health-victory-here-s.webp" type="image/webp" length="0"/>
      <media:content url="https://newscentral.site/media/us-mexico-are-on-the-verge-of-forfeiting-a-major-health-victory-here-s.webp" medium="image" width="1400" height="788"><media:title>Measles Elimination Status at Risk for US and Mexico</media:title></media:content>
    </item>
    <item>
      <title>Robert F. Kennedy Jr. Expected to Relax Peptide Regulations Following FDA Decision</title>
      <link>https://newscentral.site/robert-f-kennedy-jr-expected-to-relax-peptide-regulations-following/</link>
      <guid isPermaLink="true">https://newscentral.site/robert-f-kennedy-jr-expected-to-relax-peptide-regulations-following/</guid>
      <pubDate>Mon, 02 Nov 2026 12:00:00 GMT</pubDate>
      <dc:creator>News Central Site</dc:creator>
      <category>Style</category>
      <description><![CDATA[Health and Human Services Secretary Robert F. Kennedy Jr.'s proposal to relax restrictions on several peptides is expected to lead to significant changes in the peptide market.]]></description>
      <content:encoded><![CDATA[<p>A major shift in peptide regulations is expected following a recent announcement from Health and Human Services Secretary Robert F. Kennedy Jr.</p><p>In an interview earlier this year, Kennedy expressed his intention to direct the FDA to relax restrictions on several peptides that had been previously banned under the Biden administration.</p><p>These peptides, including BPC-157 and TB-500, were placed on the FDA's "do not compound list due to concerns over safety and a lack of comprehensive human trials.</p><p>The decision to ban these substances was made in response to their potential for serious side effects and misuse.</p><p>Kennedy has been a vocal advocate for peptides, stating that they should never have been banned in the first place. He believes this prohibition led to the emergence of a thriving black market for peptides online.</p><p>This stance is not without controversy, as many experts argue that the ban was necessary to protect public health.</p><p>For months, healthcare professionals have been waiting for the FDA to act on Kennedy's proposal.</p><p>The wait is finally over, with new regulations expected to be implemented soon.</p><p>According to insiders, the changes will likely be significant and far-reaching.</p><p>A life sciences regulatory attorney has shed light on a recent decision by the FDA that could have far-reaching implications for the peptide market. According to Asebey, who leads the FDA Practice Group at his law firm, the agency will not enforce regulations prohibiting the compounding of six specific peptides.</p><p>The FDA's decision is an example of enforcement discretion, which allows the agency to temporarily exempt certain drugs from regulatory requirements in emergency situations. In this case, the six peptides - BPC-157, TB-500, MOTS-c, Semax, KPV, and Epitalon - will be allowed to be dispensed as if they were approved by the FDA.</p><p>The move may seem unusual, but it is intended to reduce the incentive for people to obtain these peptides from unregulated sources. This includes med spas and online retailers that often skirt regulatory requirements.</p><p>A recent surge in peptide listings has been tracked by the Alliance for Safe Online Pharmacies (ASOP Global), with nearly 21,000 listings found across over 300 websites since July. This includes a significant number of listings for BPC-157, with upwards of 8,800 recorded.</p><p>The proliferation of these peptides raises concerns about quality and safety, particularly when considering the risks associated with using them even in their purest forms. As a result, a cottage industry has emerged focused on peptide purity tracking and testing services.</p><p>Meena Verma, MD, MPH, a board-certified internist and nephrologist, emphasizes the need for harm reduction given that people are already using these peptides. She views this policy change as an opportunity to address the issue more directly.</p><p>The policy shift, however, may not simplify matters as intended. With the six peptides now eligible for sale in the broader health marketplace, it becomes increasingly difficult for consumers to distinguish between legitimate and illegitimate providers.</p><p>ASOP Global has warned that the online market will likely be flooded with illegal actors who can now hide more easily among the masses without a significant risk of detection, making it harder for authorities to identify and prosecute them.</p><p>The FDA's post-DOGE workforce is significantly smaller than it was before, having lost 3,500 workers. This reduction raises questions about the agency's ability to effectively police the peptide market. The sheer scale of this market makes it a daunting task for regulatory bodies.</p><p>According to Leigh Verbois, PhD, and former director of the FDA’s Office of Drug Security, Integrity, and Response, effective policing requires more than just guardrails, it also necessitates the resources to take action. Without sufficient personnel and funds, even well-intentioned regulations may be unenforceable.</p><p>Regulatory bodies face another challenge in that some organizations intended to utilize these guardrails might not even bother to examine them. This lack of oversight could undermine efforts to regulate the peptide market effectively. It remains unclear whether the criteria outlined in Kennedy's plan will be sufficient to make a meaningful difference.</p><p>The potential risks associated with peptides are not limited to those seeking out these substances for illicit purposes. The increased accessibility of prescription drugs, including those that have yet to undergo human research, poses a risk to public health. This development could lead to unintended consequences as people may receive prescriptions for untested medications during routine medical visits.</p><p>The integration of peptides into mainstream medicine raises concerns about their safety, particularly for patients who have undergone cancer treatment.</p><p>Physicians are warning that certain peptides may not be adequately tested for potential interactions with other medications or underlying health conditions. This is especially true for patients who have had cancer and may be more susceptible to complications.</p><p>Some medical professionals argue that the administration's decision to make these peptides widely available could lead to unforeseen consequences, such as untested medications being prescribed during routine medical visits.</p><p>The irony of this situation lies in the fact that some proponents of alternative health practices are now advocating for a critical examination of mainstream medicine.</p><p>The recent surge in popularity of peptides has set a precedent for the unregulated use of supplements in mainstream medicine. This trend is likely to spill over into other areas, making it essential for consumers to be vigilant about the products they use.</p><p>Physicians and healthcare providers are facing increased pressure from patients seeking alternative treatments, often without being fully informed about their safety or efficacy. Dr Verbois emphasizes that this lack of regulation creates a wild, wild west" scenario where patients may be put at risk by unproven therapies.</p><p>In light of these developments, it is crucial for consumers to exercise caution and prioritize evidence-based treatments over untested supplements. As Dr Verbois advises, seeking out safe and effective treatments for diseases should always take precedence over the use of unregulated peptides or other alternative health products.</p><p><em>GQ</em>: <a href="https://www.gq.com/story/peptides-rfk-jr-authorized-pharmacies">https://www.gq.com/story/peptides-rfk-jr-authorized-pharmacies</a></p>]]></content:encoded>
      <enclosure url="https://newscentral.site/media/peptides-are-about-to-flood-the-market-and-bro-science-is-coming-for-u.webp" type="image/webp" length="0"/>
      <media:content url="https://newscentral.site/media/peptides-are-about-to-flood-the-market-and-bro-science-is-coming-for-u.webp" medium="image" width="1280" height="720"><media:title>Robert F. Kennedy Jr. Expected to Relax Peptide Regulations Following FDA Decision</media:title></media:content>
    </item>
    <item>
      <title>Robert F. Kennedy Jr., Department of Health and Human Services policy on peptide drugs</title>
      <link>https://newscentral.site/robert-f-kennedy-jr-department-of-health-and-human-services-policy/</link>
      <guid isPermaLink="true">https://newscentral.site/robert-f-kennedy-jr-department-of-health-and-human-services-policy/</guid>
      <pubDate>Thu, 29 Oct 2026 01:20:56 GMT</pubDate>
      <dc:creator>News Central Site</dc:creator>
      <category>Health</category>
      <description><![CDATA[The policy aims to provide patients with a more controlled option by allowing limited compounding of unapproved peptide substances under specific safeguards.]]></description>
      <content:encoded><![CDATA[<p>Robert F. Kennedy Jr., Secretary of Health and Human Services, has made a move to ease access to certain unapproved peptide drugs that are being marketed for wellness purposes. This development could have significant implications for patients seeking alternative treatments.</p><p>The policy, drafted by Kennedy, aims to provide patients with a more controlled option by allowing limited compounding of these substances under specific safeguards. Compounding pharmacies mix ingredients to create customized medications tailored to individual patients' needs.</p><p>Peptides are small proteins that can have potent effects, and while some, like insulin, are FDA-approved as safe and effective, others remain unapproved. The policy clarifies that the Department of Health and Human Services does not intend to take action against licensed pharmacies or physicians compounding drugs using non-FDA-approved peptide bulk substances.</p><p>The draft policy outlining guidelines for compounding pharmacies has sparked debate over access to unapproved peptides. In related news, GLP-1 medications used for weight loss and diabetes treatment contain FDA-approved peptides, a fact that underscores the complexity of peptide regulation.</p><p>Pharmacies will need to conduct quality testing and safety reporting under the proposed policy. This move is seen as an attempt to ensure patient safety when using unregulated sources of peptide drugs. The policy emphasizes that it does not grant FDA approval or establish clinical safety and effectiveness for these peptides.</p><p>The draft policy requires compounding pharmacies to use FDA-registered ingredient makers, obtain lab certificates for raw ingredients, and submit reports on serious side effects. A recent laboratory test conducted by CBS News found that an experimental peptide weight-loss drug purchased from a Brooklyn bodega contained unapproved peptides.</p><p>A recent laboratory test revealed that an experimental peptide weight-loss drug purchased from a Brooklyn bodega did not contain any unapproved peptide, contrary to initial findings.</p><p>Despite the lack of evidence for these peptides in certain samples, dozens of clinics across the country have been openly advertising retatrutide, a substance still under clinical trials by Eli Lilly and awaiting FDA review. Kennedy's draft policy aims to ease access to such substances, but will remain in place only until the FDA finalizes its rule on compounded peptides. The public has an opportunity to comment on this draft from Friday through November 13.</p><p><em>CBS News Health</em>: <a href="https://www.cbsnews.com/news/rfk-jr-to-ease-access-unapproved-peptides-draft-policy/">https://www.cbsnews.com/news/rfk-jr-to-ease-access-unapproved-peptides-draft-policy/</a></p>]]></content:encoded>
      <enclosure url="https://newscentral.site/media/rfk-jr-to-ease-access-to-unapproved-peptides-draft-policy-states.webp" type="image/webp" length="0"/>
      <media:content url="https://newscentral.site/media/rfk-jr-to-ease-access-to-unapproved-peptides-draft-policy-states.webp" medium="image" width="1024" height="538"><media:title>Robert F. Kennedy Jr., Department of Health and Human Services policy on peptide drugs</media:title></media:content>
    </item>
    <item>
      <title>Mifepristone Review Continues Amid Ongoing Debate</title>
      <link>https://newscentral.site/mifepristone-review-continues-amid-ongoing-debate/</link>
      <guid isPermaLink="true">https://newscentral.site/mifepristone-review-continues-amid-ongoing-debate/</guid>
      <pubDate>Thu, 08 Oct 2026 10:30:02 GMT</pubDate>
      <dc:creator>News Central Site</dc:creator>
      <category>Politics</category>
      <description><![CDATA[The FDA is reviewing the safety and efficacy of mifepristone, an abortion pill first approved in 2000, amid pressure from anti-abortion groups.]]></description>
      <content:encoded><![CDATA[<p>The FDA has provided an update on its ongoing review of the safety and efficacy of mifepristone, an abortion pill that was first approved in 2000. The agency's reevaluation of the medication has been a contentious issue, with anti-abortion groups pushing for restrictions on its use.</p><p>The FDA had previously reaffirmed the safety and effectiveness of mifepristone numerous times, even easing some restrictions on its dispensing, such as requiring it to be dispensed in person. However, since President Trump took office, there has been increased pressure from anti-abortion advocates to revisit the pill's approval.</p><p>A key figure driving this push is Health Secretary Robert F. Kennedy Jr., who ordered a review of the medication's safety. This development comes after years of debate surrounding the use of mifepristone and other abortion medications.</p><p>The FDA's progress in its reevaluation has been met with criticism from some quarters, including Gavin Oxley, a representative of Americans United for Life, an anti-abortion group.</p><p>A federal judge has ordered the FDA to provide regular updates on its ongoing review of the safety of mifepristone, a medication used in abortion procedures. This directive comes as part of a lawsuit brought by the state of Louisiana against the FDA, alleging that mail delivery of mifepristone undermines the state's abortion ban.</p><p>The case is one of several state lawsuits related to mifepristone currently making their way through the courts. However, the 5th Circuit Court of Appeals has expressed skepticism about the merits of Louisiana's lawsuit, questioning whether the state has the legal standing to challenge the FDA's oversight of the medication.</p><p>Despite this, the FDA continues to review its safety protocols for mifepristone using a statistical data mining method aimed at identifying potential unknown safety concerns. This approach involves analyzing an electronic database that collects reports of medical injuries and drug side effects from major health networks and insurers.</p><p>The Supreme Court has put changes to the medication on hold until it reviews the case again, meaning any ruling from the 5th Circuit would not have an immediate impact on the status quo.</p><p>The FDA has announced that its ongoing safety review of mifepristone will continue into next year, addressing concerns from abortion opponents about the medication's distribution and prescribing methods.</p><p>A key point of contention is the 2021 decision allowing doctors to prescribe the drug online and send it through the mail during the COVID-19 pandemic. Abortion opponents have focused on restricting this method of prescription, which they argue has made it too accessible. They aim to limit the availability of mifepristone through telehealth or by mail.</p><p>The FDA's review may not lead to a ban, but it could make access more difficult by limiting the drug's availability through online prescriptions or restricting who can prescribe it. According to medical experts, withdrawing approval would be an extraordinary step that would likely face intense legal challenges.</p><p><em>CBS News Politics</em>: <a href="https://www.cbsnews.com/news/fda-abortion-pill-mifepristone-safety-review-2027-abortion-rights-opponents-angered/">https://www.cbsnews.com/news/fda-abortion-pill-mifepristone-safety-review-2027-abortion-rights-opponents-angered/</a></p>]]></content:encoded>
      <enclosure url="https://newscentral.site/media/fda-says-its-abortion-pill-safety-review-will-continue-into-next-year.webp" type="image/webp" length="0"/>
      <media:content url="https://newscentral.site/media/fda-says-its-abortion-pill-safety-review-will-continue-into-next-year.webp" medium="image" width="1200" height="630"><media:title>Mifepristone Review Continues Amid Ongoing Debate</media:title></media:content>
    </item>
  </channel>
</rss>
